Rice University researchers find new possibilities for benign, ‘tunable’ virus
Rice University scientists have designed a tunable virus that works like a safe deposit box. It takes two keys to open it and release its therapeutic cargo.
The Rice lab of bioengineer Junghae Suh has developed an adeno-associated virus (AAV) that unlocks only in the presence of two selected proteases, enzymes that cut up other proteins for disposal. Because certain proteases are elevated at tumor sites, the viruses can be designed to target and destroy the cancer cells.
AAVs are fairly benign and have become the object of intense study as delivery vehicles for gene therapies. Researchers often try to target AAVs to cellular receptors that may be slightly overexpressed on diseased cells.
The Rice lab takes a different approach. “We were looking for other types of biomarkers beyond cellular receptors present at disease sites,” Suh said. “In breast cancer, for example, it’s known the tumor cells oversecrete extracellular proteases, but perhaps more important are the infiltrating immune cells that migrate into the tumor microenvironment and start dumping out a whole bunch of proteases as well.
“So that’s what we’re going after to do targeted delivery. Our basic idea is to create viruses that, in the locked configuration, can’t do anything. They’re inert,” she said. When programmed AAVs encounter the right protease keys at sites of disease, “these viruses unlock, bind to the cells and deliver payloads that will either kill the cells for cancer therapy or deliver genes that can fix them for other disease applications.”
Suh’s lab genetically inserts peptides into the self-assembling AAVs to lock the capsids, the hard shells that protect genes contained within. The target proteases recognize the peptides “and chew off the locks,” effectively unlocking the virus and allowing it to bind to the diseased cells.
“If we were just looking for one protease, it might be at the cancer site, but it could also be somewhere else in your body where you have inflammation. This could lead to undesirable side effects,” she said. “By requiring two different proteases – let’s say protease A and protease B – to open the locked virus, we may achieve higher delivery specificity since the chance of having both proteases elevated at a site becomes smaller.”
In the future, molecular-imaging approaches will be used to detect both the identity and concentration of elevated proteases. “With that information, we would be able to pick a virus device from our panel of engineered variants that has the right properties to target that disease site. That’s where we want to go,” she said.
Suh said elevated proteases are found around many diseased tissues. She suggested these protease-activatable viruses may be useful for the treatment of not only cancers but also neurological diseases, such as stroke, Parkinson’s and Alzheimer’s diseases, and heart diseases, including myocardial infarction and congestive heart failure.
The ultimate vision of this technology is to design viruses that can carry out a combination of steps for targeting. “To increase the specificity of virus unlocking, you can imagine creating viruses that require many more keys to open,” she said. “For example, you may need both proteases A and B as well as a cellular receptor to unlock the virus. The work reported here is a good first step toward this goal.”
The Latest on: Cancer therapy
[google_news title=”” keyword=”Cancer therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer therapy
- Forrest General Cancer Center enters 25th yearon March 1, 2024 at 2:50 pm
HATTIESBURG, Miss. (WDAM) - Cancer treatments at Forrest General Hospital has come a long way since the construction of the Forrest General Cancer Center in 1999. This month, the Cancer Center ...
- Raising awareness about colorectal canceron March 1, 2024 at 1:56 pm
He stresses the importance of scheduling a colonoscopy in the prevention and treatment of colon cancer. “It’s just one day of cleansing, and fasting a little bit, just being on a liquid diet, that’s ...
- FDA approves J&J's combination therapy for a type of lung canceron March 1, 2024 at 1:47 pm
The Food and Drug Administration approved the combination therapy of J&J's Rybrevant with carboplatin and pemetrexed for non-small cell lung cancer (NSCLC) patients with a type of mutation in EGFR ...
- Johnson & Johnson's Rybrevant Gets FDA Approval For Lung Cancer Treatmenton March 1, 2024 at 8:34 am
(RTTNews) - Johnson & Johnson (JNJ) Friday announced that the U.S. Food and Drug Administration (FDA) has approved its drug Rybrevant in combination with chemotherapy as a first-line treatment for ...
- Tuscola Fire Captain returns home following cancer treatmenton March 1, 2024 at 5:57 am
TUSCOLA, Ill. (WCIA) — A longtime member of the Tuscola Fire Department is back at home after receiving treatment for brain cancer. Captain Bill Schweighart has served in the Tuscola Fire Department ...
- Pancreatic Cancer Treatment: 6 Dietary Guidelines to Reduce The Risk of Deadly Diseaseon March 1, 2024 at 5:41 am
People diagnosed with Pancreatic cancer often find it difficult to maintain their weight and follow a healthy diet. This highly aggressive disease is rarely diagnosed at an early stage and is ...
- Colorectal cancer screening and early detection are key to effective treatmenton February 29, 2024 at 1:53 pm
With more proactive screening and advanced treatment options, the death rate associated with colorectal cancer has dropped.
- ‘Pioneering’ breakthrough paves way for new breast cancer treatmenton February 28, 2024 at 1:36 am
A breakthrough injection could pave the way for a pioneering new treatment for breast cancer, which kills thousands of women every year. Scientists have found a way to use a new cancer treatment, ...
- Cancer Treatment: New Food Supplement To Stop Deadly Cell From Spreading, Know All About Iton February 27, 2024 at 10:17 pm
One of the biggest challenges in treating cancer is stopping its spread, which can lead to death even after removing the tumor. Doctors have now developed a food supplement that prevents the spread of ...
- Self-proclaimed ‘sports nut’ turns to proton therapy for prostate cancer treatmenton February 27, 2024 at 4:00 pm
talking about his proton therapy treatment for prostate cancer at Fred Hutch. As a huge sports nut, he was drawn to learn more about proton therapy. But Lundberg also has a personal connection to the ...
via Bing News